They found that the majority of upstream BCL3-rearranged tumors had unmutated IGHV, trisomy 12, an atypical CLL morphology, immunophenotype, DNA methylome, and expression profile that differ from CLL without t(14;19). The gene discussed is BCL3; the disease is B-cell chronic lymphocytic leukemia.